IL4 and Eczematoid dermatitis: The experimental results showed that CTGO could significantly reduce IL-4 levels and increase IFN-γ levels, suggesting that CTGO may play a role in the treatment of eczema by promoting Th1/Th2 homeostasis by down-regulating IL-4 levels and up-regulating IFN-γ levels [30, 31].